Details of the Drug Reposition

General Information of This Drug (ID: DMB4OFL)

Drug Name
Darinaparsin   DMB4OFL
Synonyms ZIO-101
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Multiple myeloma DISEWP9B 2A83 Phase 2 [1]
Peripheral T-cell lymphoma DISCDT4E 2A90.C Phase 2 [2]
Hematologic tumour DIS9Y1NR 2B33.Y Phase 2 [1]
Liver cancer DISDE4BI 2C12 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00421213) Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)